The end of the Corona wave is currently casting a long shadow over the laboratory industry. The laboratory chain Synlab also continues to struggle with the sharp decline in testing for the virus. In.
David Adlington from JP Morgan retains his negative opinion on the stock with a Sell rating. The target price is being increased from EUR 28.60 to EUR 38.00.